Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,302,784
  • Shares Outstanding, K 285,419
  • Annual Sales, $ 21,840 M
  • Annual Income, $ 1,678 M
  • EBIT $ 2,578 M
  • EBITDA $ 5,040 M
  • 60-Month Beta 0.25
  • Price/Sales 2.53
  • Price/Cash Flow 8.39
  • Price/Book 2.19

Options Overview Details

View History
  • Implied Volatility 21.99% (+0.31%)
  • Historical Volatility 20.62%
  • IV Percentile 33%
  • IV Rank 21.85%
  • IV High 40.49% on 04/10/25
  • IV Low 16.81% on 02/11/25
  • Expected Move (DTE 14) 5.95 (3.05%)
  • Put/Call Vol Ratio 0.28
  • Today's Volume 549
  • Volume Avg (30-Day) 1,096
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 28,094
  • Open Int (30-Day) 18,255
  • Expected Range 189.23 to 201.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.82
  • Number of Estimates 7
  • High Estimate 2.85
  • Low Estimate 2.79
  • Prior Year 3.43
  • Growth Rate Est. (year over year) -17.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
162.29 +20.27%
on 11/06/25
196.36 -0.60%
on 11/21/25
+18.79 (+10.65%)
since 11/05/25
3-Month
162.29 +20.27%
on 11/06/25
196.36 -0.60%
on 11/21/25
+2.79 (+1.45%)
since 09/05/25
52-Week
162.29 +20.27%
on 11/06/25
251.99 -22.54%
on 02/03/25
-27.06 (-12.18%)
since 12/05/24

Most Recent Stories

More News
BD and ChemoGLOâ„¢ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories

FRANKLIN LAKES, N.J. , Dec. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and ChemoGLOâ„¢, a specialist in hazardous drug detection...

BDX : 195.64 (+0.97%)
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes

Three- and Four-Laser BD FACSDiscoverâ„¢ A8 Cell Analyzers Expand Accessibility of Spectral, Real-Time Imaging Cell Analysis

BDX : 195.64 (+0.97%)
Is Becton, Dickinson and Company Stock Underperforming the Nasdaq?

Becton, Dickinson and Company has notably underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.

SOLV : 85.41 (+0.18%)
$NASX : 23,571.04 (+0.28%)
BDX : 195.64 (+0.97%)
BD Surgiphorâ„¢ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety

FRANKLIN LAKES, N.J. , Nov. 24, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD Surgiphorâ„¢...

BDX : 195.64 (+0.97%)
1 Profitable Stock to Own for Decades and 2 We Avoid

1 Profitable Stock to Own for Decades and 2 We Avoid

PRIM : 123.16 (-2.15%)
BDX : 195.64 (+0.97%)
MAIN : 60.73 (+1.25%)
3 Healthcare Stocks We Approach with Caution

3 Healthcare Stocks We Approach with Caution

PACB : 2.37 (-5.95%)
BDX : 195.64 (+0.97%)
BRKR : 48.03 (-0.72%)
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors

FRANKLIN LAKES, N.J. , Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Robert "Robbie"...

BDX : 195.64 (+0.97%)
BD Onclarityâ„¢ HPV Assay for BD CORâ„¢ and BD Viperâ„¢ LT Systems Receive WHO Prequalification

RANKLIN LAKES, N.J. , Nov. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE)...

BDX : 195.64 (+0.97%)
What Are Wall Street Analysts' Target Price for Becton, Dickinson and Company Stock?

Although Becton, Dickinson and Company has underperformed the broader market over the past year, Wall Street analysts maintain a measured optimism about the company’s long-term outlook.

XLV : 153.51 (-0.25%)
$SPX : 6,878.04 (+0.31%)
BDX : 195.64 (+0.97%)
Duncan Regional Hospital Becomes First in U.S. to Implement BD Alarisâ„¢ EMR Infusion Interoperability with MEDITECH

FRANKLIN LAKES, N.J. , Nov. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Duncan Regional Hospital ("DRH...

BDX : 195.64 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 196.55
2nd Resistance Point 195.33
1st Resistance Point 194.54
Last Price 195.64
1st Support Level 192.53
2nd Support Level 191.31
3rd Support Level 190.53

See More

52-Week High 251.99
Fibonacci 61.8% 217.72
Fibonacci 50% 207.14
Fibonacci 38.2% 196.55
Last Price 195.56
52-Week Low 162.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar